Stroke
August 2018 each arterial black void was measured first. A second measurement was taken perpendicular to the first to account for naturally occurring variation in arterial curvature. Both measurements were averaged to obtain the axial diameter of each of the 3 arteries (Figure [A] ). The interreader intraclass correlation coefficient was 0.74 for the right internal carotid artery, 0.67 for the left internal carotid artery, and 0.93 for the BA.
Statistical Analysis
Enzymatic activity was expressed first in µmol/L per hour and then adjusted for a batch effect. 12 The distribution of each enzyme was inverted and log-transformed. We ran collinearity diagnostics with the 5 lysosomal enzymes used for this study and found tolerance of <0.83 in all cases, variance inflation of <1.58, and a condition index of <14. Based on these, we analyzed the lysosomal enzymes individually and then together in 1 regression model. We created models with progressive adjustment for possible confounders and tested for nonlinear association using generalized additive models. The statistical analysis was performed with SAS software, version 9.4 (SAS Institute Inc, Cary, NC).
Results
The study included 107 participants, 98 Parkinson disease patients, and 9 controls. The median age was 67. Seventytwo were men, and 102 were non-Hispanic white (Table 1) . Thirty-five participants (32.7%) had hypertension, 11 (10.3%) had diabetes mellitus, 45 (42.1%) had dyslipidemia, and 34 (31.8%) had a prior history of smoking. The associations between demographics, cardiovascular risk factors, and brain arterial diameters are reported in Table I in the onlineonly Data Supplement.
The scatterplots of both GLA enzymatic activity and GAA enzymatic activity by brain arterial diameters suggested a linear association, with the steepest slopes noted for the BA. For both enzymes, association with the BA diameter remained significant after adjusting for multiple covariates ( Table 2) .
The strength of association between BA diameter and lower GAA and GLA activities was similar in men and women but appeared greater among participants without Parkinson disease and when the time between the brain magnetic resonance imaging and the blood measurement was >1 year apart (average time difference overall was 9 months).
Discussion
In this study, we found a significant association between lower GLA or GAA activities and BA dilatation, independent of demographic, and vascular risk factors (Table 2 ; model 2). The stronger association of lower GLA and GAA activities with BA dilatation, compared with internal carotid artery dilatation, could be because of differences in architecture between the anterior and posterior intracranial arteries, with posterior arteries containing less elastin, thinner vessel walls, and increased concentric intimal thickening. 13 These results should be interpreted in the context of its strengths and limitations. We used a convenience sample of consecutive participants in a Parkinson biomarker study and data on cardiovascular risk factors was self-reported. Although subgroup analysis suggested an even greater association for controls (without Parkinson), a larger sample of controls should be tested. In addition, magnetic resonance imaging measurements were made using clinical scans from T2 black voids, which may not be as precise as time-of-flight magnetic resonance angiography or computed tomographic angiography to measure the actual luminal diameter. This lack of precision increases measurement error and type II error. Consequently, we may have underestimated the strength of the reported associations.
Summary
We found a significant association between increased BA diameter and lower GLA and GAA enzymatic activities, which suggest a role for lysosomes in brain arterial dilatation in nonsyndromic populations. If these results are confirmed in larger samples, therapies aimed at modifying lysosomal enzymatic activity may conceivably be tested among patients with dolichoectasia. Model 0 was adjusted for the magnet strength of the magnetic resonance imaging (MRI), MRI vendor, and the duration between the brain MRI and the enzymatic activity reading. Model 1 was adjusted for model 0 plus age, sex, ethnicity, and height. Model 2 was adjusted for model 1 plus hypertension, diabetes mellitus, dyslipidemia, and smoking. Model 3 was adjusted for model 2 plus Parkinson disease.
